Establishment of a screening model for endometrial cancer and precancerous lesions based on the near-infrared fluorescent probe ZW-FA

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200058317

Enrollment

Unknown

Registered

2022-04-05

Start date

2022-03-22

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial cancer

Interventions

Endometrial cancer patients group:None

Group of patients with other non-malignant diseases:None

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Patients undergoing total hysterectomy. 2. Agree to participate in this study and sign the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Acute inflammation of the reproductive system (except atrophic vaginitis); 2. Patients with malignant tumors other than endometrial cancer such as cervical cancer and ovarian cancer; 3. Patients with abnormal coagulation function and other blood system diseases that affect coagulation; 4. The amount of bleeding is large, and emergency curettage is needed to stop the bleeding; 5. Those whose body temperature exceeds 37.5? twice on the day of treatment.

Design outcomes

Primary

Measure	Time frame
The fluorescence intensity;Sensitivity of the model;Specificity of the model;Accuracy of the model;Age;Body mass index;Diabetes;Hypertension;	—

Countries

China

Contacts

Public ContactLi Qiling

liqiling@mail.xjtu.edu.cn+86 18991232838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026